P934: THE EFFECTS OF EXTRAMEDULLARY DISEASE ON OUTCOMES OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

P934: THE EFFECTS OF EXTRAMEDULLARY DISEASE ON OUTCOMES OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

Bibliographic Details
Main Authors:	Yi Tao, Shiwei Jin, Yan Wang, Sijie Tang, Yuanfang Liu, Jie Xu, Weiping Zhang, Mengmeng Pan, Jian‑qing MI
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000970640.40049.e0

Similar Items

Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma
by: JingSong He, et al.
Published: (2021-07-01)

Survival trends and prognostic factors of patients with newly diagnosed multiple myeloma accompanied with extramedullary disease
by: Jing Wang, et al.
Published: (2023-12-01)

Bone-Related Extramedullary Disease in Newly Diagnosed Myeloma Patients is an Independent Poor Prognostic Predictor
by: Ying Wang, et al.
Published: (2022-07-01)

Extramedullary disease in multiple myeloma
by: Radhika Bansal, et al.
Published: (2021-09-01)

Incidence of Extramedullary Myeloma in Multiple Myeloma Patients
by: Sinan Demircioğlu, et al.
Published: (2019-07-01)

Genetic Abnormalities in Extramedullary Multiple Myeloma
by: Roisin McAvera, et al.
Published: (2023-07-01)

P934: DARATUMUMAB + LENALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: A POST HOC ANALYSIS OF SUSTAINED MINIMAL RESIDUAL DISEASE NEGATIVITY FROM GRIFFIN
by: C. Rodriguez, et al.
Published: (2022-06-01)

Daratumumab in untreated newly diagnosed multiple myeloma
by: Nadine Abdallah, et al.
Published: (2019-12-01)

Advances in the treatment of extramedullary disease in multiple myeloma
by: Yating Li, et al.
Published: (2022-08-01)

Pomalidomide-based therapy for extramedullary multiple myeloma
by: Yating Li, et al.
Published: (2022-12-01)

Value of Peripheral Blood Cell Count and Its Ratio in Evaluating Prognosis of Newly Diagnosed Multiple Myeloma Patients with Non-bone-related Extramedullary Diseases
by: JING Yaoyao, et al.
Published: (2019-05-01)

Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma
by: Juan Xu, et al.
Published: (2021-06-01)

Multiple myeloma with extramedullary plasmacytoma: pathogenesis and clinical case
by: M. V. Firsova, et al.
Published: (2022-11-01)

Relapsed multiple myeloma with gastric and pancreatic extramedullary plasmacytomas
by: Hong Han Lin, et al.
Published: (2023-04-01)

Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma
by: Yi Tao, et al.
Published: (2024-04-01)

Muscle and fat composition in patients with newly diagnosed multiple myeloma
by: Nadine H. Abdallah, et al.
Published: (2023-12-01)

Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas
by: Martin Stork, et al.
Published: (2022-10-01)

Evaluation of the clinico-laboratory manifestations of newly diagnosed multiple myeloma
by: Angela Ogechukwu Ugwu
Published: (2022-01-01)

Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
by: Mir Sadaqat Hassan Zafar, et al.
Published: (2018-01-01)

HOW I TREAT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS?
by: María-Victoria Mateos
Published: (2021-11-01)

Changing landscape of induction therapy in newly diagnosed multiple myeloma
by: Nidhi Tandon, et al.
Published: (2019-01-01)

Characteristics and prognostic value of extramedullary chromosomal abnormalities in extramedullary myeloma
by: Yuan Xia, et al.
Published: (2022-10-01)

Clinical significance of granule‐containing myeloma cells in patients with newly diagnosed multiple myeloma
by: Kazuhito Suzuki, et al.
Published: (2016-11-01)

The choice of regimens based on bortezomib for patients with newly diagnosed multiple myeloma.
by: Jingsong He, et al.
Published: (2014-01-01)

PB1974: MULTIVARIATE SPECTRAL BIOTYPING OF EXTRAMEDULLARY MULTIPLE MYELOMA
by: M. Vlachová, et al.
Published: (2022-06-01)

Gastric involvement: A rare extramedullary location of multiple myeloma
by: Cláudia Pedrosa, et al.
Published: (2020-11-01)

A prognostic model for patients with primary extramedullary multiple myeloma
by: Limei Zhang, et al.
Published: (2022-11-01)

Extramedullary disease in multiple myeloma: a systematic literature review
by: Joan Bladé, et al.
Published: (2022-03-01)

Spontaneous spleen rupture: an unusual presentation of extramedullary multiple myeloma
by: Maria Eduarda Bini de Abreu, et al.
Published: (2020-10-01)

Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse
by: Jan Smetana, et al.
Published: (2018-01-01)

Uterine Extramedullary Plasmacytoma as a Primary Manifestation of Multiple Myeloma
by: Ana Codorniz, et al.
Published: (2017-09-01)

Extramedullary multiple myeloma in the spermatic cord: A case report
by: Austin Lee, et al.
Published: (2021-03-01)

Analysis of High-Risk Extramedullary Relapse Factors in Newly Diagnosed MM Patients
by: Xiaoyan Yue, et al.
Published: (2022-12-01)

Extramedullary Myeloma to the Liver Following Bispecific Antigen T-Cell Treatment for Refractory Multiple Myeloma
by: Joelle St-Pierre, et al.
Published: (2022-01-01)

Baseline peripheral neuropathy was associated with age and a prognostic factor in newly diagnosed multiple myeloma patients
by: Mengmeng Dong, et al.
Published: (2022-06-01)

Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma
by: Melania Carlisi, et al.
Published: (2024-02-01)

The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients
by: Michał Mielnik, et al.
Published: (2023-11-01)

A simple additive staging system for newly diagnosed multiple myeloma
by: Nadine H. Abdallah, et al.
Published: (2022-01-01)

Clinical Significance of TP53 Abnormalities in Newly Diagnosed Multiple Myeloma
by: Fang Ye, et al.
Published: (2021-12-01)

A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?
by: Uros Markovic, et al.
Published: (2019-09-01)